← Back to Search

Behavioral Intervention

Power to Prevent for Childhood Obesity (TELE-GEN Trial)

N/A
Waitlist Available
Led By Abigail Gamble, PhD, MS
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline child hemoglobin a1c to 30-weeks
Awards & highlights

TELE-GEN Trial Summary

This study is evaluating whether a diabetes prevention program can be delivered via telehealth to help prevent type 2 diabetes in African American children.

Eligible Conditions
  • Childhood Obesity
  • Prediabetes
  • Obesity

TELE-GEN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline child hemoglobin a1c to 30-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline child hemoglobin a1c to 30-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child BMI z-score
Parent BMI
Secondary outcome measures
Child Hemoglobin A1c
Child diastolic blood pressure
Child out-of-school sedentary time
+21 more
Other outcome measures
Child tanner stage

TELE-GEN Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention
Eligible overweight/obese children and their overweight/obese parent (N=20 families) will receive the same telehealth diabetes prevention intervention based on Power to Prevent and delivered by a trained lifestyle coach. Families will meet weekly for 11-weeks (60-min sessions), and then monthly (60-min sessions) for 4 pilot behavioral reinforcement maintenance sessions (15 sessions total). Participants will meet in their respective groups (n=5 families per group) via videoconference using Wi-Fi-enabled tablets with cellular connectivity for the entire intervention. Sessions will consist of nutrition and physical activity behavior change strategies (20 min), problem solving and decision-making skills to circumvent barriers to behavioral change (20 min), and family goal setting and action planning (20 min). Assessment measures will be collected from the child and parent participants at baseline, 12-weeks (post-intervention), and 30-weeks (follow-up).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Power to Prevent
2020
N/A
~40

Find a Location

Who is running the clinical trial?

University of Mississippi Medical CenterLead Sponsor
173 Previous Clinical Trials
195,049 Total Patients Enrolled
Abigail Gamble, PhD, MSPrincipal InvestigatorUniversity of Mississippi Medical Center
3 Previous Clinical Trials
534 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025